LONG-TERM EFFECTIVENESS AND ACCEPTABILITY OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: THE REMSWITCH-LT STUDY

Anthony Buisson  1     Maria Nachury  2     MaĆ«va Bazoges  1     Clara Yzet  3     Pauline Wils  4     Marie Dodel  1     Dilek Coban  1     Bruno Pereira  1     Mathurin Fumery  3    
1 CHU Estaing Clermont-Ferrand, Clermont-Ferrand, France
2 CHRU Lille, Courbevoie Cedex, France
3 Amiens University Hospital, Amiens, France
4 CHRU Lille, Lille Cedex, France

Topic
IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing